Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Texas Capital to Bring Corporate Listing Home to the Texas Stock Exchange
-
Data Safety Monitoring Board (DSMB) Recommends Continuing BriaCell’s Phase 3 Metastatic Breast Cancer Study
-
Auction result of Treasury Bills - RIKV 26 1216 - RIKV 27 0317
-
Pan Global Successful in Bid For Rights to Salamón Gold Project, Spain
-
Transactions in connection with share buyback programme
-
Edible Garden Showcases the Farm-to-Formula® Future of Clean Nutrition and Ready-to-Drink Innovation at ECRM
-
Blake Rhodes Assumes the Role of Chairman of the Board of ERDA
-
Important Notice to Long-Term Shareholders of FuelCell Energy, Inc. (NASDAQ: FCEL); Insulet Corporation (NASDAQ: PODD); Papa John's International, Inc. (NASDAQ: PZZA); and York Space Systems Inc. (NYS
-
Hub Group Announces Select Preliminary First and Second Quarter 2026 Financial Results and Provides Update on Restatement Process
-
Hub Group Announces Leadership Changes
-
Shanghai Droi Technology Unveils DroiClaw 3 and Wide-Format Agentic Smartphone at RMB 999
-
Form 8.3 - Eleco Plc
-
Services opening-up unlocks more China opportunities
-
As New York Fashion Week Kicks Off, Kraig Labs Advances Spider Silk for Fashion's Next Generation of Designers
-
ModelOp CEO Dave Trier to Address BIIA Technology FORUM on AI Governance as Credit and Business Information Industry Enters the Agentic AI Era
-
Global Service Trade Digital Development Index Report 2026 Released
-
Apollo Silver Reaffirms Its Support for Ejido Benito Juárez on Long Term Water Solutions
-
Mavenir Celebrates Four Award-Winning Entries at Light Reading's 2026 Leading Lights Awards
-
Talisker Provides 2026 Operational Update
-
Photonic Inc. unveils Project VANGUARD, a proposal for a $500M specialized semiconductor manufacturing facility to accelerate commercialization of quantum, AI and defence innovation in Canada
-
Belo Sun Mining Provides Update on Proceedings Related to the Installation License for the Volta Grande Gold Project In Brazil
-
Corbus Pharmaceuticals Announces Positive Topline Data from CANYON-1 Study of Daily Oral CRB-913 for the Treatment of Obesity
-
Highwoods Announces Leasing and Disposition Activity
-
NexGold’s Goldboro Project Selected for Inclusion in the Canada Investment Summit Prospectus
-
Pharmazz, Inc. Receives U.S. FDA Orphan Drug Designation for Sovateltide for the Treatment of Neonatal Hypoxic-Ischemic Encephalopathy (NHIE)
-
AirJoule Technologies Acquires BitSink, Adding Profitable AI & HPC Infrastructure Cooling Business
-
The QPAREB releases its Quebec Housing Landscape
-
Cyllene Therapeutics Receives U.S. FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for EG110A in Neurogenic Detrusor Overactivity (NDO)
-
Brazil Potash Reduces Upfront Capex with 28-Year Construction & Backup Power Contract
-
Canadian Premium Sand Inc. Announces Participation in Canada Investment Summit
-
Cyllene Therapeutics Receives U.S. FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for EG110A in Neurogenic Detrusor Overactivity (NDO)
-
GeNeuro, Inc., an NRx Company (Nasdaq:NRXP) is awarded European Patent Rights for GNK-301, a novel drug candidate to treat Amyotrophic Lateral Sclerosis (ALS)
-
Passport Couriers Engaging in Widespread Deception, According to TINA.org
-
Osisko Gold Announces Formal Construction Decision and Development Update for the Cariboo Gold Project
-
Department of Energy Mandates Centralia Unit 2 Remain Available for Operation for Additional 90 Days
-
Pasithea Therapeutics Announces Presentation of Initial PAS-004 Clinical Data from Ongoing Phase 1/1b Clinical Trial in Adult NF1 Patients at the 2026 European Neurofibromatosis Conference
-
AirJoule Technologies Acquires BitSink, Adding Profitable AI & HPC Infrastructure Cooling Business
-
Senseonics Announces Strategic Partnership with Beta Bionics to Integrate Eversense® 365 with the iLet® Bionic Pancreas
-
Brazil Potash Reduces Upfront Capex with 28-Year Construction & Backup Power Contract
-
Asimov Announces Cell Line Development Partnership with Sidewinder Therapeutics to Advance 4-Chain Bispecific Antibody for Solid Tumors
-
Cullinan Therapeutics to Host Virtual Analyst and Investor Event Today to Feature Zipalertinib Plus Chemotherapy Phase 3 REZILIENT3 Data Presented at the IASLC 2026 World Conference on Lung Cancer
-
Macerich To Present at BofA Securities 2026 Global Real Estate Conference
-
Mavenir Celebrates Four Award-Winning Entries at Light Reading's 2026 Leading Lights Awards
-
INmune Bio Appoints Sanofi Rare-Disease Executive and Biopharma Business Development Leader to Board
-
Independent DSMB Recommends MediWound’s EscharEx® Phase III VALUE Study Continue Without Modification
-
Hop Valley Brewing Co. Makes Its Downtown Eugene Comeback with New Pub at 5th Street Public Market
-
Psyence BioMed Establishes Texas Ibogaine Research Corporation to Advance U.S. Ibogaine Development
-
VisionWave Files U.S. Non-Provisional Patent Application Describing ARGUS™, a Proposed Space-Enabled, AI-Driven Counter-Drone Defense Architecture
-
Lyell Immunopharma To Participate in the Baird 2026 Global Healthcare Conference
-
Ashland Innovation Day to be held September 17, 2026
